Experienced scientist for target and drug discovery innovation
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Hørsholm
Are you passionate about pushing the boundaries of drug discovery? Do you have a keen eye for novel biological, pharmaceutical, and technological innovations while maintaining the critical thinking necessary to evaluate their potential? Can you thrive in a dynamic, fast-paced environment where you focus on specific, high-impact projects, all while contributing to a broader discovery initiative? If so, then we have a unique career opportunity where you will have the chance to shape the future of target and drug discovery at Gubra.
As Gubra is experiencing rapid growth, we are expanding our Drug Discovery Innovation team. We are seeking an ambitious experienced scientist with a risk-taking mindset who will be a key player in identifying and kick-starting innovation projects to feed Gubra’s Discovery pipeline. In this team our work is primarily based on accessible data and we do not perform wet-lab activities. You will report directly to Director of Drug Discovery Innovation, Morten Lundh.
Your primary areas of responsibility will include:
• Identify and evaluate novel biological targets, with a focus on peptide-based drug discovery opportunities.
• Initiate and lead innovative projects that align with Gubra’s strategic goals in drug discovery.
• Collaborate with a diverse group of skilled scientists across various teams at Gubra to bring innovative ideas to life.
• Communicate key findings to internal stakeholders.
Qualifications:
• Life science background at PhD level e.g., molecular/cell-biology, chemistry, pharmaceutical or medical science.
• Extensive experience in the drug discovery industry, with a track record of successful innovation.
• A passion for innovation and the ability to navigate the risks associated with pioneering new ideas.
• Strong analytical skills and the ability to critically assess new discoveries.
• Strong oral and written communication and presenting skills in English.
You will be appointed on a Senior or Principal Scientist level, depending on qualifications and experience.
Please apply no later than Monday 2nd of September, 2024, by uploading your motivated cover letter, resume and relevant diplomas on our website. Please apply as soon as possible and note that applications will be reviewed on an ongoing basis. If you have questions about the position, please contact Morten Lundh, Director of Drug Discovery Innovation, at [email protected].
About Gubra
Gubra is an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the fight for a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of +240 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by intensive drive, scientific curiosity, and teamwork – we join forces!
As Gubra is experiencing rapid growth, we are expanding our Drug Discovery Innovation team. We are seeking an ambitious experienced scientist with a risk-taking mindset who will be a key player in identifying and kick-starting innovation projects to feed Gubra’s Discovery pipeline. In this team our work is primarily based on accessible data and we do not perform wet-lab activities. You will report directly to Director of Drug Discovery Innovation, Morten Lundh.
Your primary areas of responsibility will include:
• Identify and evaluate novel biological targets, with a focus on peptide-based drug discovery opportunities.
• Initiate and lead innovative projects that align with Gubra’s strategic goals in drug discovery.
• Collaborate with a diverse group of skilled scientists across various teams at Gubra to bring innovative ideas to life.
• Communicate key findings to internal stakeholders.
Qualifications:
• Life science background at PhD level e.g., molecular/cell-biology, chemistry, pharmaceutical or medical science.
• Extensive experience in the drug discovery industry, with a track record of successful innovation.
• A passion for innovation and the ability to navigate the risks associated with pioneering new ideas.
• Strong analytical skills and the ability to critically assess new discoveries.
• Strong oral and written communication and presenting skills in English.
You will be appointed on a Senior or Principal Scientist level, depending on qualifications and experience.
Please apply no later than Monday 2nd of September, 2024, by uploading your motivated cover letter, resume and relevant diplomas on our website. Please apply as soon as possible and note that applications will be reviewed on an ongoing basis. If you have questions about the position, please contact Morten Lundh, Director of Drug Discovery Innovation, at [email protected].
About Gubra
Gubra is an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the fight for a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of +240 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by intensive drive, scientific curiosity, and teamwork – we join forces!
Information og data
Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Hørsholm.
Jobbet er oprettet på vores service den 16.8.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forsker
- Hørsholm
- Mandag den 02. september 2024
Lignende jobs
-
Lead/Specialist Research Scientist within Bioassay...
Would you like to make an impact on improving the quality of life of millions suffering from allergic diseases? Do you have an analytical and curious mindset? Do like to be part of a drug discovery..Få mere info- Forsker
- Hørsholm
-
Innovate and Inspire as a Biotech Research Scienti...
Do you thrive exploring innovative new ways to solve scientific challenges? At [xxxxx]TechBio LAB, we’re a team of thinkers, doers, and collaborators who believe in the power of innovation to .Få mere info- Forsker
- Hørsholm
-
PhD scholarship in Reproductive Toxicology - DTU F...
Få mere info- Forsker
- Klampenborg
-
PhD scholarship in Human Decision-Making and Immer...
Få mere info- Forsker
- Klampenborg
Statistik over udbudte jobs som forskere i Hørsholm
Herunder ser du udviklingen i udbudte forsker i Hørsholm over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.
Se flere statistikker her:
Statistik over udbudte forskere i Hørsholm over tid
| Dato | Alle jobs som forskere |
|---|---|
| 23. december 2024 | 4 |
| 22. december 2024 | 4 |
| 21. december 2024 | 4 |
| 20. december 2024 | 4 |
| 19. december 2024 | 4 |
| 18. december 2024 | 2 |
| 17. december 2024 | 2 |
| 16. december 2024 | 2 |
| 15. december 2024 | 2 |
| 14. december 2024 | 2 |
| 13. december 2024 | 2 |
| 12. december 2024 | 2 |
| 11. december 2024 | 2 |
| 10. december 2024 | 2 |
| 9. december 2024 | 2 |
| 8. december 2024 | 2 |
| 7. december 2024 | 2 |
| 6. december 2024 | 2 |
| 5. december 2024 | 1 |
| 4. december 2024 | 1 |
| 3. december 2024 | 1 |
| 2. december 2024 | 1 |
| 1. december 2024 | 2 |
| 30. november 2024 | 2 |
| 29. november 2024 | 2 |
| 28. november 2024 | 2 |
| 27. november 2024 | 2 |
| 26. november 2024 | 2 |
| 25. november 2024 | 2 |
| 24. november 2024 | 2 |
| 23. november 2024 | 2 |